Venus Concept

Company Overview

Snapshot

Founded in February 2009 by Oded Ron-Edoute and Orit Ron-Edoute, Venus Concept operates with 201–500 employees. The company has raised a total of $113.05M across 8 funding rounds from 8 investors. In November 2019, Venus Concept became public on NASDAQ.

Business overview

Venus Concept develops and markets medical aesthetic devices, offering a broad portfolio of minimally invasive and noninvasive technologies. The company's product lines include aesthetic device platforms such as Venus Versa and Venus Legacy, alongside hair restoration systems like NeoGraft and the. Serving over 60 countries and 29 direct markets, Venus Concept operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Aesthetic Devices.

Strategic signal

In May 2024, Venus Concept announced a $35 million Debt-to-Equity Exchange Transaction. This strategic financial maneuver indicates the company's proactive approach to optimizing its capital structure and reducing debt burden, which could improve financial stability and investor confidence in its long-term growth prospects.

Company Intelligence Q&A

What was a significant recent financial transaction for Venus Concept?

In May 2024, Venus Concept announced a $35 million Debt-to-Equity Exchange Transaction, aiming to restructure its financial obligations.

When did Venus Concept go public?

Venus Concept became public on NASDAQ in November 2019.

What was the total capital raised by Venus Concept?

Venus Concept has raised a total of $113.05 million across 8 funding rounds.

What was a key product approval for Venus Concept in 2024?

In September 2024, Venus Concept announced Australian regulatory approval for its Venus Bliss MAX system.

What was a significant debt restructuring event for Venus Concept in 2023?

In October 2023, Venus Concept Inc. announced a debt restructuring, alongside preliminary third-quarter 2023 revenue results and updated fiscal year 2023 revenue guidance.